The Global In Vitro Diagnostics (IVD) market was valued at USD 106.9 Billion in 2023 which is further expected to reach USD 202.9 Billion in 2032 at a CAGR of 25.2%. In vitro diagnostics (IVDs) are ...

Siemens Healthineers announced today it has initiated the carve-out process for its in vitro diagnostics business, marking an ...

The partnership will advance VIVA-ELISA® industrialization. The Spanish biotechnology company and German CDMO join ...

Siemens Healthineers will carve out its in vitro diagnostics business as a standalone company operating under the name ...

There is plenty of change happening at Siemens Healthineers as the company is now rebranding to Healthineers and carving out ...

The Van Gogh Microscopy System is a US FDA class I in vitro diagnostic medical device that uses Dynamic Cell Imaging ...

The IVD opportunity is moving beyond test volumes: leaders must assess where diagnostics can shorten care pathways, enable precision medicine and shift testing closer to the patient. Wilmington, DE, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. When we picture U.S. manufacturing, several flagship ...

bioMérieux's Latest 32,000 sq. ft. Global Food Safety and Quality Site is Home to the xPRO™ Program that Rapidly Innovates Cutting-Edge Molecular Assays in Partnership with Industry Leaders Since 2019 ...

Quest Diagnostics is emphasizing the critical role of in vitro diagnostics (IVDs) in shaping modern healthcare and advancing precision medicine, according to Dr. Neelam Dhiman, director of science for ...

As the pandemic escalated, in August 2020, the Trump administration Health and Human Services (HHS) directed the Food and Drug Administration (FDA) to stop requesting premarket approval for clinical ...

To provide regulators and professionals responsible for the selection of in vitro diagnostic tests in countries with a comprehensive understanding of the importance and benefits of developing a ...